<p>賓夕法尼亞州巴拉辛伍德，2025 年 6 月 13 日（全球新聞通訊）——Brodsky &amp; Smith 提醒投資者關注以下調查。如果您持有股份並希望討論該調查，請聯繫 Jason Brodsky（jbrodsky@brodskysmith.com）或 Marc Ackerman（mackerman@brodskysmith.com），電話 855-576-4847。您無需承擔任何費用或財務義務。</p>
<p><strong>CureVac N.V.（納斯達克 - CVAC）</strong></p>
<p>根據合併協議的條款，CureVac 將被 BioNTech SE（納斯達克 - BNTX）收購。每股 CureVac 將兑換約 5.46 美元的 BioNTech 美國存托股票，CureVac 的隱含總股本價值約為 12.5 億美元。交易完成後，CureVac 的股東預計將持有 BioNTech 約 4% 至 6% 的股份。調查關注 CureVac 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括考慮是否為公司的股東提供了公平的價值。</p>
<p>更多信息請訪問 https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
<p><strong>Know Labs, Inc.（紐約證券交易所美國 - KNW）</strong></p>
<p>根據協議條款，Know Labs 將被 Goldeneye 1995 LLC（“買方”）收購，買方是金融科技投資者、企業家及前 Ripple 首席風險官 Greg Kidd 的關聯公司。買方將收購通過將（i）1,000 個比特幣的總和與用於償還現有債務、贖回未償還優先股和提供額外營運資金的現金總和相除，得到的公司普通股數量，除以（ii）每股購買價格 0.335 美元。調查關注 Know Labs 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括該交易是否為公司的股東提供了公平的價值。</p>
<p>更多信息請訪問 https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
<p><strong>Volato Group, Inc.（紐約證券交易所美國 - SOAR）</strong></p>
<p>根據協議條款，Volato Group 將與 M2i Global, Inc.（“M2i Global”）（場外交易 - MTWO）合併。M2i Global 將獲得 Volato Group 的普通股，使其持有約 90% 的 Volato 的普通股總數。調查關注 Volato Group 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括合併公司對股東的稀釋問題。</p>
<p>更多信息請訪問 https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
<p><strong>Heliogen, Inc.（場外交易 - HLGN）</strong></p>
<p>根據合併協議的條款，Heliogen 將被 Zeo Energy Corp.（“Zeo Energy”）收購。交易完成後，Heliogen 的證券持有人將根據 Zeo Class A 普通股的每股價格 1.5859 美元，獲得總值約 1000 萬美元的 Zeo Class A 普通股，並根據交易完成時 Heliogen 的淨現金情況進行調整。調查關注 Heliogen 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括考慮是否為公司的股東提供了公平的價值。</p>
<p>更多信息請訪問 https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/.</p>
<p>Brodsky &amp; Smith 是一家訴訟律師事務所，擁有豐富的經驗，代表全國各地的股東進行證券和集體訴訟。Brodsky &amp; Smith 的律師已被全國多個法院任命為集體訴訟的首席律師，併成功為我們的客户和股東追回了數百萬美元。律師廣告。以往的結果並不保證類似的結果。</p>

HLGN

SOAR

CVAC

USBC

<p>Brodsky & Smith 正在通知投資者有關對幾家公司進行調查的情況，調查內容涉及其董事會在收購過程中可能違反受託責任。這些公司包括 CureVac N.V.、Know Labs, Inc.、Volato Group, Inc. 和 Heliogen, Inc. 每項調查的重點是董事會是否進行了公平的程序，並在各自的合併協議中為股東提供了公平的價值。投資者可以聯繫 Brodsky & Smith 獲取更多信息，無需承擔任何財務義務</p>

<p>BALA CYNWYD, Pa., June 13, 2025 (GLOBE NEWSWIRE) — Brodsky &amp; Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason Brodsky (jbrodsky@brodskysmith.com) or Marc Ackerman (mackerman@brodskysmith.com) at 855-576-4847. There is no cost or financial obligation to you.</p>
<div class="lb-trans"><p>賓夕法尼亞州巴拉辛伍德，2025 年 6 月 13 日（全球新聞通訊）——Brodsky &amp; Smith 提醒投資者關注以下調查。如果您持有股份並希望討論該調查，請聯繫 Jason Brodsky（jbrodsky@brodskysmith.com）或 Marc Ackerman（mackerman@brodskysmith.com），電話 855-576-4847。您無需承擔任何費用或財務義務。</p>
</div><p><strong>CureVac N.V. (Nasdaq - CVAC)</strong></p>
<div class="lb-trans"><p><strong>CureVac N.V.（納斯達克 - CVAC）</strong></p>
</div><p>Under the terms of the Merger Agreement, CureVac will be acquired by BioNTech SE (Nasdaq – BNTX). Each CureVac share will be exchanged for approx. $5.46 in BioNTech ADSs, resulting in an implied aggregate equity value for CureVac of approx. $1.25 billion. Upon closing of the transaction, CureVac shareholders are expected to own between 4% and 6% of BioNTech. The investigation concerns whether the CureVac Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根據合併協議的條款，CureVac 將被 BioNTech SE（納斯達克 - BNTX）收購。每股 CureVac 將兑換約 5.46 美元的 BioNTech 美國存托股票，CureVac 的隱含總股本價值約為 12.5 億美元。交易完成後，CureVac 的股東預計將持有 BioNTech 約 4% 至 6% 的股份。調查關注 CureVac 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括考慮是否為公司的股東提供了公平的價值。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
<div class="lb-trans"><p>更多信息請訪問 https://www.brodskysmith.com/cases/curevac-n-v-nasdaq-cvac/.</p>
</div><p><strong>Know Labs, Inc. (NYSE American - KNW)</strong></p>
<div class="lb-trans"><p><strong>Know Labs, Inc.（紐約證券交易所美國 - KNW）</strong></p>
</div><p>Under the terms of the agreement, Know Labs will be acquired by Goldeneye 1995 LLC (“Buyer”), an affiliate of fintech investor, entrepreneur, and former Ripple Chief Risk Officer, Greg Kidd. Buyer will acquire that number of shares of the Company’s common stock obtained by dividing (i) the sum of 1,000 Bitcoin and a cash sum to retire existing debt, redeem outstanding preferred equity and provide additional working capital, by (ii) the per share purchase price of $0.335. The investigation concerns whether the Know Labs Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the deal provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根據協議條款，Know Labs 將被 Goldeneye 1995 LLC（“買方”）收購，買方是金融科技投資者、企業家及前 Ripple 首席風險官 Greg Kidd 的關聯公司。買方將收購通過將（i）1,000 個比特幣的總和與用於償還現有債務、贖回未償還優先股和提供額外營運資金的現金總和相除，得到的公司普通股數量，除以（ii）每股購買價格 0.335 美元。調查關注 Know Labs 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括該交易是否為公司的股東提供了公平的價值。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
<div class="lb-trans"><p>更多信息請訪問 https://www.brodskysmith.com/cases/know-labs-inc-nyse-american-knw/.</p>
</div><p><strong>Volato Group, Inc. (NYSE American - SOAR)</strong></p>
<div class="lb-trans"><p><strong>Volato Group, Inc.（紐約證券交易所美國 - SOAR）</strong></p>
</div><p>Under the terms of the agreement, Volato Group will merge with M2i Global, Inc. (“M2i Global”) (OTC - MTWO). M2i Global will receive common shares of Volato Group stock such that M2i Global will own approximately 90% of the total shares of common stock of Volato. The investigation concerns whether the Volato Group Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including the dilution to the Company’s shareholders in the combined company.</p>
<div class="lb-trans"><p>根據協議條款，Volato Group 將與 M2i Global, Inc.（“M2i Global”）（場外交易 - MTWO）合併。M2i Global 將獲得 Volato Group 的普通股，使其持有約 90% 的 Volato 的普通股總數。調查關注 Volato Group 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括合併公司對股東的稀釋問題。</p>
</div><p>Additional information can be found at https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
<div class="lb-trans"><p>更多信息請訪問 https://www.brodskysmith.com/cases/volato-group-inc-nyse-american-soar/.</p>
</div><p><strong>Heliogen, Inc. (OTC - HLGN)</strong></p>
<div class="lb-trans"><p><strong>Heliogen, Inc.（場外交易 - HLGN）</strong></p>
</div><p>Under the terms of the Merger Agreement, Heliogen will be acquired by Zeo Energy Corp.  (“Zeo Energy”). Upon the closing of the transaction, Heliogen’s securityholders will receive shares of Zeo’s Class A common stock valued at approximately $10 million in the aggregate, based on a Zeo Class A common stock price of $1.5859 per share, and subject to an adjustment mechanism based on Heliogen’s net cash at the closing. The investigation concerns whether the Heliogen Board breached its fiduciary duties to shareholders by failing to conduct a fair process, including whether the consideration provides fair value to the Company’s shareholders.</p>
<div class="lb-trans"><p>根據合併協議的條款，Heliogen 將被 Zeo Energy Corp.（“Zeo Energy”）收購。交易完成後，Heliogen 的證券持有人將根據 Zeo Class A 普通股的每股價格 1.5859 美元，獲得總值約 1000 萬美元的 Zeo Class A 普通股，並根據交易完成時 Heliogen 的淨現金情況進行調整。調查關注 Heliogen 董事會是否因未能進行公平程序而違反了對股東的信託責任，包括考慮是否為公司的股東提供了公平的價值。</p>
</div><p>Additional information can be found at . https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/,</p>
<div class="lb-trans"><p>更多信息請訪問 https://www.brodskysmith.com/cases/heliogen-inc-otc-hlgn/.</p>
</div><p>Brodsky &amp; Smith is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky &amp; Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.</p>
<div class="lb-trans"><p>Brodsky &amp; Smith 是一家訴訟律師事務所，擁有豐富的經驗，代表全國各地的股東進行證券和集體訴訟。Brodsky &amp; Smith 的律師已被全國多個法院任命為集體訴訟的首席律師，併成功為我們的客户和股東追回了數百萬美元。律師廣告。以往的結果並不保證類似的結果。</p>
</div>

BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: CureVac N.V. (Nasdaq - CVAC), Know Labs, Inc. (NYSE American - KNW), Volato Group, Inc. (NYSE American - SOAR), Heliogen, Inc. (OTC - HLGN)

GlobeNewswire

Heliogen

Volato

CureVac BV

Know Labs

BRODSKY & SMITH 股東更新：通知投資者關於以下公司的調查：CureVac N.V.（納斯達克 - CVAC）、Know Labs, Inc.（紐約證券交易所美國市場 - KNW）、Volato Group, Inc.（紐約證券交易所美國市場 - SOAR）、Heliogen, Inc.（場外交易市場 - HLGN）